IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
1.475
-0.065 (-4.22%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands.
The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
IM Cannabis Corp.
| Country | Israel |
| Founded | 1980 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam, Central District Tel Aviv, 4690500 Israel | |
| Website | imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Eyal Fisher | Chief Executive Officer of the IMC Holdings |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Oren Shuster | Executive Chairman and Chief Executive Officer |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel and Secretary |
| Anna Taranko | Director Investor and Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 3, 2025 | 6-K | Report of foreign issuer |
| Mar 31, 2025 | 6-K | Report of foreign issuer |
| Mar 31, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 20, 2025 | 6-K | Report of foreign issuer |
| Mar 5, 2025 | 6-K | Report of foreign issuer |
| Feb 5, 2025 | 6-K | Report of foreign issuer |
| Jan 17, 2025 | 6-K | Report of foreign issuer |
| Jan 6, 2025 | 6-K | Report of foreign issuer |
| Dec 4, 2024 | 6-K | Report of foreign issuer |